EN IN
EN IN

Product

Biologics

  • NABOTA™

    50, 100, 200Units / vial-Inj.

    Botulinum toxin type A

    Indication

    - Temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients (Approved in KR, US, EU, Canada)
    - Treatment of upper limb spasticity in adult patients (Approved in KR)
    - Temporary improvement in the appearance of moderate to severe lateral canthal lines associated with orbicularis oculi activity in adult patients (Approved in KR)
    - Treatment of blepharospasm associated with dystonia in adult patients (Approved in KR)
    - HI PureTM Technology (KR patent No.13-39349, US Patent No. 9,512,418)

  • CareTropin™

    22.5IU (7.5mg) - Cartridge Pen Type Inj.

    Somatropin (human growth hormone)

    Indication

    Growth hormone replacement therapy in adults with growth hormone deficiency

  • Eposis™

    2000, 3000, 4000, 5000, 6000, 8000, 10000IU / Pre-filled syringe Inj.

    rhEPO (recombinant human erythropoietin)

    Indication

    Growth hormone replacement therapy in adults with growth hormone deficiency

  • Epodion™

    2000, 3000, 4000, 10000IU / Pre-filled syringe Inj.

    rhEPO (recombinant human erythropoietin)

    Indication

    Anemia in chronic renal failure

  • Easyef™

    0.5㎎/10㎖ / Topical Solution(Spray)

    rhEGF (=recombinant human Epidermal Growth Factor)

    Indication

    Diabetic foot ulcer

Chemicals

  • Fexuclue™

    40mg / - Tab

    Fexuprazan HCl

    Indication

    Erosive Gastroesophageal Reflux Disease
    (erosive GERD)

  • ENVLO®

    0.3mg / - Tab

    Enavogliflozin

    Indication

    adult with type 2 diabetes mellitus

  • V-OLET

    20mg/2mL Vial/Inj.

    Deoxycholic Acid

    Indication

    Improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults

  • Luphere™ Depot

    3.75mg / Pre-filled syringe Inj.

    Leuprorelin Acetate

    Indication

    Prostate cancer, Endometriosis, Pre-menopausal breast cancer, Uterine leiomyomata (Fibroids), Central Precocious Puberty

  • Olostar™

    10/5, 10/10, 20/5, 20/10, 20/20, 40/10/, 40/20mg - Tab.

    Olmesartan medoxomil, Rosuvastatin

    Indication

    Concomitant Hypertension and Dyslipidemia

  • URSA™

    200, 300mg Tab. 200, 250mg Hard Cap.

    UDCA (Ursodeoxycholic Acid)

    Indication

    PBC, Hepatitis C, Gallstone disease, Prevention of Gallstone

CTD List

Biologics

Classification Brand Name Active Ingredient Strength Dosage Form
Central Nervous System NABOTA Botulinum Toxin Type A 50, 100, 200Units Inj.
Endocrinology CareTropin Somatropin 22.5IU Cartridge Inj.
Musculoskeletal Novosis rhBMP-2 0.25mg, 1mg, 3mg Lyophilized Powder
Nephrology Eposis rhEPO 2000IU, 3000IU,4000IU, 5000IU,6000IU, 8000IU,10000IU Prefilled Syringe Inj.
Wound Easyef Solution rhEGF 5mg/10ml Topical Solution
Wound Easyef Ointment rhEGF 1ug/g Ointment

Chemical

Classification Brand Name Active Ingredient Strength Dosage Form
Endocrine Envlo Enavogliflozin 50, 100, 200Units Tab.
Gastrointestinal Fexuclue Fexuprazan HCl 22.5IU Tab.
Obesity V-OLET Deoxycholic Acid 0.25mg, 1mg, 3mg Vial/Inj.
Antineoplastics Luphere Depot Leuprorelin acetate 0.25mg, 1mg, 3mg Vial
Cardiovascular Olostar Olmesartan medoxomil/ Rosuvastatin 20mg/10mg, 40mg/20mg Tab.
Cardiovascular Olomax Olmesartan medoxomil/Amlodipine/ Rosuvastatin 40/10/20mg, 40/10/10mg
40/5/10mg, 20/5/10mg		 Tab.
Cardiovascular DW Pitavastatin Pitavastatin calcium 2mg Tab.
Cardiovascular Crezet Ezetimibe / Rosuvastatin 10mg/5mg, 10mg/10mg,10mg/20mg Tab.
Gastrointestinal URSA Ursodeoxycholic acid 100mg, 200mg, 250mg, 300mg Tab.
Gastrointestinal URSA Ursodeoxycholic acid 250mg Tab.
Gastrointestinal URSA Ursodeoxycholic acid 100mg Cap.
Metabolic Risenplus Risedronate Sodium 35 mg Tab.
Antiviral Tamivict Oseltamivir Phosphate 30mg, 45mg, 75mg Cap.

OTC

Classification Brand Name Active Ingredient Strength Dosage Form
Analgesic EZN 6 Pro Dexibuprofen 300mg Soft Cap.
Antacid Newlanta Al₂O₃ / Mg(OH)₂ 200mg/400mg Suspension
Digestive Bearse Multi-enzymes(incl.Biodiastase 2000 III,Lipase I,Ursodeoxycholic Acid) - Tab.
Iron Supplement Hemo Q Plus Polysaccharide iron complex/Cyanocobalamin 0.1%/Folic acid 5mg/10ml Topical Solution
Muti-Vitamin Impactamin Power Vitamin B Complex (incl. Benfotiamin) - Tab.

Under development

Classification Brand Name Active Ingredient Strength Dosage Form
Gastrointestinal Phase II DWP305401 - Cap.
Antiviral Formulation Tenofovir Alafenamide Fumarate 25mg Tab.
Antineoplastics Formulation Leuprorelin acetate - DCS
Central Nervous System Pre-clinical Aripiprazole Monohydrate 300mg, 400mg Vial / Inj.
COVID-19 Phase I Niclosamide - Vial (Long acting Inj)
COVID-19 (Human Stem cell) Phase I DWP710 - Vial)
Androgenetic alopecia Phase I
Pre-clinical		 Finasteride - 1M depot Inj.
3M depot Inj.

Devices

Classification Brand Name Active Ingredient Strength Dosage Form
IVD Marketed COVID-19 PCR Kit buffer, Enzyme, Control etc. 100 test/box
IVD Marketed COVID-19 IgG/IgM RDT Kit, buffer, pipette 20EA/box
Medical Device Marketed UTM/VTM : Viral transport medium Transport medium+2 swabs (Nasopharyngeal, Oropharyngeal) 50EA/box
IVD Marketed COVID-19 Rapid PCR Kit buffer, Enzyme, Control, 8 cap strip & 96 well plates 100 test/box
IVD Marketed COVID-19 antigen rdt Test device, buffer, filter cap, nasal swab 25 test/box